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1275outweighs the selection of the bifurcation stenting
technique. As for DCB, it seems useful for ISR after
bifurcation stenting, and thus allowing prevention of
neointimal hyperplasia and avoiding excessive DES.Young-Hak Kim, MD, PhD
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Breast Cancer Survivors
A Possible Choice but Always With CautionWe read with great interest the article by Yadav et al.
(1) and want to congratulate the authors on their
extensive experience in this complicated ﬁeld. Radial
access has become the route of default for cardiac
catheterization and percutaneous intervention in
many centers. However, the fear of a possible lym-
phedema in breast cancer survivors has always been
present and frequently is perceived as a contraindi-
cation. The article by Yadav and colleagues represents
an important advance demonstrating the safety in a
large series of patients. However, we would like to add
some information that we consider relevant. Our
group has much experience using the radial access (2),
and it has been our ﬁrst choice in diagnostic and
therapeutic interventions since 2003. Although
a history of breast cancer has never represented acontraindication, we had 1 negative experience with a
78-year-oldwomanwith rightmastectomy in 1993who
was admitted with a non–ST-segment elevation
myocardial infarction. In 2005, we had already per-
formed a cardiac catheterization through the right
radial artery with 6-F catheters without complications.
Another angiography was indicated in 2012 through
the same right radial artery and in the current proce-
dure a 0.014 Whisper wire (Abbott Vascular, Irvine,
California) and a 4-F JR4 catheter were needed to go
through a stenosis at the level of the elbow, and later
on a 6-F guiding catheter was required to perform an
intravascular ultrasound interrogation of the left main
artery. During the procedure, a slight resistance was
felt in the elbow with the movements of the 6-F
catheter. In the next 4 h, a hematoma developed in
the patient’s elbow with signiﬁcant lymphedema of
the arm. The perimeter of the right arm reached 34
cm compared with 25 cm in the left arm.
Conservative management with elevation of the right
arm, cessation of clopidogrel, and maintenance of
aspirin were indicated, although 3 weeks were
necessary to resolve the complication due to the
delayed reabsorption of the edema. Another case
with a serious complication was previously described
(3). The series described by Yadav et al. demonstrates
that the ipsilateral radial artery is one of the possible
routes for performing angiography in these patients,
but we should keep in mind that in case of
complications, there may be a limited capacity to
resolve. We believe that probably the most correct
procedure should be to approach the contralateral
radial or even ulnar arteries ﬁrst (4) and, in case of
failure, then to evaluate the condition of the femoral
arteries and the risk of bleeding to choose the most
adequate approach between the ipsilateral artery or
the femoral access. In addition, as Saito et al. (5)
reported that only 71.5% of females have radial
arteries with a diameter larger than a 6-F catheter,
every effort should be made to reduce the size of the
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